Our Thursday Green Deals are being headlined by an exciting exclusive deal for our readers on the Yozma IN 10 Off-Road ...
FDA advisors have voted against approval of Eli Lilly and Innovent Biologics' cancer immunotherapy sintilimab, undermining hopes of a new, lower-priced option in the PD-1/PD-L1 inhibitor class. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results